Effect of prophylactic use ketorolac with pethidine for prevention of shivering and pain

Comparison of prophylactic use ketorolac with pethidine for prevention of shivering and pain after cesarean section under spinal anesthesia

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20201207049639N2

Enrollment

Registered

2020-12-30

Start date

2019-11-23

Completion date

Unknown

Last updated

2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain. Acute pain, not elsewhere classified

Interventions

Intervention 1: Intervention group 1: In the first intervention group, patients received 30 mg of intravenous Ketorolac (Produced by Caspian) 10 minutes before spinal anesthesia. Intervention 2: Inter

Eligibility

Sex/Gender

Female

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Age between 18 to 40 years old American Society of Anesthesiologists (ASA) I and II Candidate for cesarean

Exclusion criteria

Exclusion criteria: Dissatisfaction to participate in the study Sensitivity to Non-steroidal anti-inflammatory drugs (NSAIDs)

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: At recovery, one hour after surgery, 24 hours after surgery. Method of measurement: Visual analogue Scale (VAS).;Shivering. Timepoint: At recovery. Method of measurement: observation (Having / not having shivering).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Hadi Hooshyar

Oroumia University of Medical Sciences

hooshyar.h@umsu.ac.ir+98 44 3198 8293

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026